Andrew A.G. Aprikyan

Prevalence of mutations in <i>ELANE</i>, <i>GFI1</i>, <i>HAX1</i>, <i>SBDS</i>, <i>WAS</i> and <i>G6PC3</i> in patients with severe congenital neutropenia

Jun Xia, Audrey Anna Bolyard, Elin Rodger et al. · British Journal of Haematology · 2009 · 166 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression ofbcl-x in neutrophil precursors

Andrew A.G. Aprikyan, W. Conrad Liles, Julie R. Park et al. · Blood · 2000 · 114 citations

Life Sciences, Genetics, Hematology +14

The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome

David C. Dale, Audrey Anna Bolyard, Merideth L. Kelley et al. · Blood · 2011 · 98 citations

Medicine, Oncology, Pharmacology +5

Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia

Philip S. Rosenberg, Blanche P. Alter, Daniel C. Link et al. · British Journal of Haematology · 2007 · 97 citations · Full text

Medicine, Genetics, Hematology +16

Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells

Göran Carlsson, Andrew A.G. Aprikyan, Ramin Tehranchi et al. · Blood · 2004 · 89 citations · Full text

Life Sciences, Cell Biology, Molecular Genetics +13